POZEN Inc. (POZN) Receives Decision from AstraZeneca (AZN) to File PN 400 NDA

May 13, 2009 7:54 AM EDT Send to a Friend
POZEN Inc. (NASDAQ: POZN) reported that AstraZeneca (NYSE: AZN) has made the decision to have POZEN file the New Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login